Form: 10-K/A

Annual report pursuant to Section 13 and 15(d)

April 30, 2021

Documents

EXHIBIT 31.2

 

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Dov Elefant, Chief Financial Officer, Cellectar Biosciences, Inc., certify that:

 

  1. I have reviewed this Amendment No. 1 to the annual report on Form 10-K/A of Cellectar Biosciences, Inc.; and

 

  2. Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

  /s/ Dov Elefant
Date:  April 30, 2021 Dov Elefant
  Chief Financial Officer